205 related articles for article (PubMed ID: 23020925)
21. TBX2 controls a proproliferative gene expression program in melanoma.
Lu S; Louphrasitthiphol P; Goradia N; Lambert JP; Schmidt J; Chauhan J; Rughani MG; Larue L; Wilmanns M; Goding CR
Genes Dev; 2021 Dec; 35(23-24):1657-1677. PubMed ID: 34819350
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta targets PAX3 to control melanocyte differentiation.
Moustakas A
Dev Cell; 2008 Dec; 15(6):797-9. PubMed ID: 19081068
[TBL] [Abstract][Full Text] [Related]
23. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
24. FOXD3 Promotes PAX3 Expression in Melanoma Cells.
Kubic JD; Little EC; Kaiser RS; Young KP; Lang D
J Cell Biochem; 2016 Feb; 117(2):533-41. PubMed ID: 26252164
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo.
Lagha M; Sato T; Regnault B; Cumano A; Zuniga A; Licht J; Relaix F; Buckingham M
BMC Genomics; 2010 Dec; 11():696. PubMed ID: 21143873
[TBL] [Abstract][Full Text] [Related]
26. Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung.
Lüdtke TH; Wojahn I; Kleppa MJ; Schierstaedt J; Christoffels VM; Künzler P; Kispert A
Respir Res; 2021 Mar; 22(1):85. PubMed ID: 33731112
[TBL] [Abstract][Full Text] [Related]
27. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling.
Kamaraju AK; Bertolotto C; Chebath J; Revel M
J Biol Chem; 2002 Apr; 277(17):15132-41. PubMed ID: 11830592
[TBL] [Abstract][Full Text] [Related]
28. T-box binding protein type two (TBX2) is an immediate early gene target in retinoic-acid-treated B16 murine melanoma cells.
Boskovic G; Niles RM
Exp Cell Res; 2004 May; 295(2):281-9. PubMed ID: 15093729
[TBL] [Abstract][Full Text] [Related]
29. Pax3( GFP ) , a new reporter for the melanocyte lineage, highlights novel aspects of PAX3 expression in the skin.
Djian-Zaouche J; Campagne C; Reyes-Gomez E; Gadin-Czerw S; Bernex F; Louise A; Relaix F; Buckingham M; Panthier JJ; Aubin-Houzelstein G
Pigment Cell Melanoma Res; 2012 Sep; 25(5):545-54. PubMed ID: 22621661
[TBL] [Abstract][Full Text] [Related]
30. FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription.
Dong L; Li Y; Cao J; Liu F; Pier E; Chen J; Xu Z; Chen C; Wang RA; Cui R
Cell Death Differ; 2012 Apr; 19(4):616-22. PubMed ID: 21997191
[TBL] [Abstract][Full Text] [Related]
31. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
Gershon TR; Oppenheimer O; Chin SS; Gerald WL
Neoplasia; 2005 Jun; 7(6):575-84. PubMed ID: 16036108
[TBL] [Abstract][Full Text] [Related]
32. Investigation of downstream target genes of PAX3c, PAX3e and PAX3g isoforms in melanocytes by microarray analysis.
Wang Q; Kumar S; Mitsios N; Slevin M; Kumar P
Int J Cancer; 2007 Mar; 120(6):1223-31. PubMed ID: 17187370
[TBL] [Abstract][Full Text] [Related]
33. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis.
Cai CL; Zhou W; Yang L; Bu L; Qyang Y; Zhang X; Li X; Rosenfeld MG; Chen J; Evans S
Development; 2005 May; 132(10):2475-87. PubMed ID: 15843407
[TBL] [Abstract][Full Text] [Related]
34. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations.
Corry GN; Underhill DA
Pigment Cell Res; 2005 Dec; 18(6):427-38. PubMed ID: 16280008
[TBL] [Abstract][Full Text] [Related]
35. PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN.
Li HG; Wang Q; Li HM; Kumar S; Parker C; Slevin M; Kumar P
Cancer Lett; 2007 Aug; 253(2):215-23. PubMed ID: 17350164
[TBL] [Abstract][Full Text] [Related]
36. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
[TBL] [Abstract][Full Text] [Related]
37. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
McGill GG; Horstmann M; Widlund HR; Du J; Motyckova G; Nishimura EK; Lin YL; Ramaswamy S; Avery W; Ding HF; Jordan SA; Jackson IJ; Korsmeyer SJ; Golub TR; Fisher DE
Cell; 2002 Jun; 109(6):707-18. PubMed ID: 12086670
[TBL] [Abstract][Full Text] [Related]
38. FGF signaling regulates expression of Tbx2, Erm, Pea3, and Pax3 in the early nasal region.
Firnberg N; Neubüser A
Dev Biol; 2002 Jul; 247(2):237-50. PubMed ID: 12086464
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro.
Wang Q; Kumar S; Slevin M; Kumar P
Cancer Res; 2006 Sep; 66(17):8574-80. PubMed ID: 16951170
[TBL] [Abstract][Full Text] [Related]
40. Pax3 transcripts in melanoblast development.
Blake JA; Ziman MR
Dev Growth Differ; 2005 Dec; 47(9):627-35. PubMed ID: 16316407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
